Table 2.

Drug-related parameters.

Drug	Bevacizumab	Ranibizumab	Rituximab	Conbercept	Aflibercept
Molecular weight (kDa)	149	48	145	143	115
Bolus dose (mg)	1.25	0.50	1.00	0.50	1.20
Sustained release dose (mg)	3.75	1.50	3.00	1.50	3.60
Reference	[14]	[15]	[16]	[17]	[18]